DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antineoplastic and Immunomodulating Agentss are 7




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_3563IFN-alpha2a
Antineoplastic and Immunomodulating Agentss
Hepatitis C virus | Hairy cell leukemia | AIDS-related Kaposi's sarcoma | Leukemia
Chikungunya virus
181/clone 25
NA
Plaque assay
Decrease (50 %)
Approved, Investigational
30354193
DrugRepV_3564IFN-alpha2a
Antineoplastic and Immunomodulating Agentss
Hepatitis C virus | Hairy cell leukemia | AIDS-related Kaposi's sarcoma | Leukemia
Chikungunya virus
181/clone 25
NA
Plaque assay
Decrease (50 %)
Approved, Investigational
30354193
DrugRepV_3565IFN-alpha2a
Antineoplastic and Immunomodulating Agentss
Hepatitis C virus | Hairy cell leukemia | AIDS-related Kaposi's sarcoma | Leukemia
Chikungunya virus
181/clone 25
NA
Plaque assay
Decrease (50 %)
Approved, Investigational
30354193
DrugRepV_5546Ponatinib
Antineoplastic and Immunomodulating Agentss
Chronic myeloid leukemia
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved, Investigational
32353859
DrugRepV_5554Midostaurin
Antineoplastic and Immunomodulating Agentss
Acute myeloid leukemia (AML)
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved, Investigational
32353859
DrugRepV_5555Ruxolitinib
Antineoplastic and Immunomodulating Agentss
Bone marrow cancer
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved
32353859
DrugRepV_5562Daunorubicin
Antineoplastic and Immunomodulating Agentss
Cancer
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved
32353859